Evaluation of pharmacodynamic (PD) biomarkers in advanced cancer patients treated with oxidative phosphorylation (OXPHOS) inhibitor, OPC-317 (OPC)

J.Q. Eu,K. Yadav,Y.-C. Lim, J. Hirpara, L.R. Kong, Z.C. Ng, V.K. Lee, S.C. Lee,D.S. Tan, R.A. Soo, C.E. Chee, W.P. Yong,R. Sundar, J.S. Lim,L. Wang, N. Ohi, T. Tsunoda, S. Pervaiz,B.-C. Goh, A.L. Wong

ANNALS OF ONCOLOGY(2019)

引用 0|浏览44
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要